Literature DB >> 16369325

Topics in pediatric leukemia--acute myeloid leukemia.

Jerry Cheng1, Kathleen M Sakamot.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16369325      PMCID： PMC1681379     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  25 in total

Review 1.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

Review 2.  Molecular genetics of acute myeloid leukaemia.

Authors:  A Dash; D G Gilliland
Journal:  Best Pract Res Clin Haematol       Date:  2001-03       Impact factor: 3.020

3.  Annexin II and bleeding in acute promyelocytic leukemia.

Authors:  J S Menell; G M Cesarman; A T Jacovina; M A McLaughlin; E A Lev; K A Hajjar
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

4.  Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.

Authors:  S C Raimondi; M N Chang; Y Ravindranath; F G Behm; M V Gresik; C P Steuber; H J Weinstein; A J Carroll
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

5.  Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

Authors:  Jeffrey E Rubnitz; Susana C Raimondi; Xin Tong; Deo Kumar Srivastava; Bassem I Razzouk; Sheila A Shurtleff; James R Downing; Ching-Hon Pui; Raul C Ribeiro; Frederick G Behm
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

6.  A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

Authors:  W G Woods; S Neudorf; S Gold; J Sanders; J D Buckley; D R Barnard; K Dusenbery; J DeSwarte; D C Arthur; B J Lange; N L Kobrinsky
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

7.  Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821.

Authors:  S K Parsons; S Gelber; B F Cole; Y Ravindranath; A Ogden; A M Yeager; M Chang; J Shuster; H J Weinstein; R D Gelber
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

Review 8.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 9.  Acute leukemia: a pediatric perspective.

Authors:  James R Downing; Kevin M Shannon
Journal:  Cancer Cell       Date:  2002-12       Impact factor: 31.743

10.  Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.

Authors:  Christian M Zwaan; Dirk Reinhardt; Selim Corbacioglu; Elisabeth R van Wering; Jos P M Bökkerink; Wim J E Tissing; Ulf Samuelsson; Jay Feingold; Ursula Creutzig; Gertjan J L Kaspers
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113
View more
  1 in total

1.  IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia.

Authors:  Hongjuan Xue; Haili Gao; Hong Xia; Shaofei Li; Na Li; Chao Gao; Yuwen Duan; Yanfei Ren; Henglu Zhang; Jingzheng Liu; Wei Gao
Journal:  J Clin Lab Anal       Date:  2021-03-11       Impact factor: 2.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.